Showing results (2101-2110 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|February 15, 2024
Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled TrialsBrian Moseley, Dimitrios Bourikas, Svetlana Dimova, et al.
Advances in Therapy|February 16, 2024
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 TrialsTakayuki Hamano, Yusuke Yamaguchi, Kashia Goto, et al.
Advances in Therapy|March 14, 2024
Adverse Drug Events Observed with the Newly Approved Remimazolam in Comparison to Propofol for General Anesthesia in Patients Undergoing Surgery: A Meta-analysisLidan Huang, Hong Liu, Xue Zou, et al.
Advances in Therapy|March 11, 2024
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative ReviewJessica R Allegretti, Jessica H Brady, Ann Wicker, et al.
Advances in Therapy|March 11, 2024
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional AnalysisLarry Culpepper, Ashley Martin, Nadia Nabulsi, et al.
Advances in Therapy|March 12, 2024
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to MenopauseAki Shiozawa, Shayna Mancuso, Christopher Young, et al.
Advances in Therapy|July 3, 2024
Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic SyndromeRaymond C Chang, Ryan L Miller, Katherine W Kwon, et al.
Advances in Therapy|July 22, 2024
Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment ComparisonKoutaro Yokote, Riku Ota, Shogo Wada, et al.
Advances in Therapy|July 22, 2024
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in SpainManuel Botana López, Miguel Camafort Babkowski, Raquel Campuzano Ruiz, et al.
Advances in Therapy|July 8, 2024
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World StudyYael Barer, Olga Sánchez-Soliño, Gabriel Chodick, et al.
Pageof 457